EBGCR has a patient-focused clinical research team focused on comprehensive, safe care through clinical trials. Several of our principal investigators joined Encore Borland Groover Clinical Research (EBGCR) after having vibrant academic careers in clinical research. Many of our investigators are also lead authors of cutting-edge manuscripts in scientific journals.
Our research team has a long history with many leading pharmacology, private research and development centers worldwide. We are actively involved in pharmacologic outcome clinical trials especially with new agents in Phase I through Phase III. Currently, we are able to offer patients access to new drugs in clinical trials years before they become commercially available.